Assenagon Asset Management S.A. Oramed Pharmaceuticals Inc. Transaction History
Assenagon Asset Management S.A.
- $39.3 Billion
- Q2 2024
A detailed history of Assenagon Asset Management S.A. transactions in Oramed Pharmaceuticals Inc. stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 16,419 shares of ORMP stock, worth $39,569. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,419
Previous 18,659
12.0%
Holding current value
$39,569
Previous $54,000
22.22%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding ORMP
# of Institutions
65Shares Held
6.37MCall Options Held
0Put Options Held
0-
Murchinson Ltd. Toronto, A61.7MShares$4.1 Million0.77% of portfolio
-
Bml Capital Management, LLC Zionsville, IN1.35MShares$3.25 Million2.47% of portfolio
-
Boothbay Fund Management, LLC New York, NY825KShares$1.99 Million0.06% of portfolio
-
Morgan Jess S & CO Inc366KShares$883,0262.07% of portfolio
-
Rathbones Group PLC Liverpool, X0290KShares$698,4250.0% of portfolio
About ORAMED PHARMACEUTICALS INC.
- Ticker ORMP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,827,100
- Market Cap $93.6M
- Description
- Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...